ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 327 out of 1121

$539K Total Retail Price of All Prescriptions

Rank: 361 out of 1121

477 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 477 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,264 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 621 414 1 1
AMLODIPINE BESYLATE 460 372 2 5
OMEPRAZOLE 353 211 3 6
METFORMIN HCL 305 196 4 8
LISINOPRIL 287 169 5 4
MELOXICAM 280 172 6 22
WARFARIN SODIUM 270 148 7 11
FUROSEMIDE 266 180 8 7
LEVOTHYROXINE SODIUM 229 108 9 2
METOPROLOL TARTRATE 221 133 10 9
GLIMEPIRIDE 185 120 11 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 91 12 31
POTASSIUM CHLORIDE 154 112 13 12
ALENDRONATE SODIUM 137 97 14 37
HYDROCHLOROTHIAZIDE 130 64 15 10
SINGULAIR 121 69 16 78
ATORVASTATIN CALCIUM 121 82 16 15
BENAZEPRIL HCL 118 85 18 41
CARVEDILOL 118 79 18 20
GABAPENTIN 103 45 20 13
INSULIN SYRINGE 100 55 21 77
ALLOPURINOL 97 66 22 30
TRIAMTERENE-HCTZ 96 53 23 38
TAMSULOSIN HCL 95 58 24 32
CRESTOR 94 47 25 28
HYDRALAZINE HCL 91 66 26 66
FLUTICASONE PROPIONATE 87 45 27 36
PROAIR HFA 86 46 28 48
LANTUS 84 54 29 52
SPIRONOLACTONE 80 35 30 54
AMLODIPINE BESYLATE-BENAZEPRIL 79 39 31 65
DIOVAN 77 64 32 45
KLOR-CON 10 77 57 32 69
CLOPIDOGREL 73 60 34 27
SPIRIVA 72 53 35 49
DONEPEZIL HCL 71 55 36 35
LOSARTAN POTASSIUM 70 42 37 17
CITALOPRAM HBR 68 36 38 18
GLYBURIDE 68 46 R 38 51
ATENOLOL 66 25 40 16
PAROXETINE HCL 63 32 41 58
KLOR-CON M20 62 41 42 85
PLAVIX 59 51 43 42
TRICOR 57 16 44 126
GLIPIZIDE 55 52 45 84
SYMBICORT 55 30 45 148
MONTELUKAST SODIUM 54 23 47 144
NASONEX 53 31 48 260
NEXIUM 52 35 49 24
LANTUS SOLOSTAR 50 40 50 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.